Protein Aggregation in Biopharmaceuticals: Control Strategies and Recent Trends
The importance of managing protein aggregation in the biopharmaceutical industry has been highlighted by the increasing demand for high-concentration Subcutaneous (SC) formulations and Intravenous (IV) injections, as well as the emergence of complex novel modalities such as bispecific antibodies. Protein aggregatio...